1 Min Read
March 20 (Reuters) - COSMO PHARMACEUTICALS NV:
* ANNOUNCES SUBMISSION TO FDA OF NEW DRUG APPLICATION FOR RIFAMYCIN SV MMX Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.